Combination treatment for acute myeloid leukemia (AML)

• 收藏
• 分享

专利权人:

Hoffmann-La Roche Inc.

发明人:

Brian Higgins,Gwen Nichols,Kathryn E. Packman

申请号：

US14560086

公开号：

US09956243B2

申请日:

2014.12.04

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to a pharmaceutical product comprising a) as a first component an inhibitor of the MDM2-p53 interaction such as, for example:and b) as a second component cytarabine； as a combined preparation for the sequential or simultaneous use in the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/